Bit Capital Gmb H C4 Therapeutics, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$3.6 - $7.0 $500,036 - $972,293	-138,899 Closed	0 $0
Q3 2024 Feb 12, 2025	BUY	$4.43 - $7.38 $615,322 - $1.03 Million	138,899 New	138,899 $792 Million
Q2 2024 Feb 12, 2025	SELL	$4.05 - $8.1 $680,764 - $1.36 Million	-168,090 Closed	0 $0
Q1 2024 Feb 12, 2025	BUY	$5.3 - $11.0 $890,877 - $1.85 Million	168,090 New	168,090 $1.37 Billion
Q1 2022 Feb 12, 2025	BUY	$19.99 - $33.23 $75,962 - $126,273	3,800 New	3,800 $92.2 Million

125

63.4M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $158M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.